CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy

Study Identifier
MedAff BTX-0718
CT.gov Identifier
NCT00836017
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Movement Disorders - Other
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosed with Cervical Dystonia * Candidate for botulinum toxin type A therapy * New to physician's practice, and/or new to botulinum toxin type A therapy, or has not been injected with botulinum toxin type A for at least 16 weeks as a participant in another clinical trial investigating botulinum toxin type A for cervical dystonia * Able to follow study instructions and complete study activities
    Exclusion Criteria:
    * Patients undergoing elective surgery during the trial period * Females who are pregnant, nursing, or planning a pregnancy * History of poor cooperation or compliance with medical treatment or unreliability * Any condition or situation in which, in the investigator's opinion, places the patient at significant risk, could confound the study data, or may interfere with the patient's participation in the study, including but not limited to unstable medical conditions

    Protocol Summary

    This study is an observational trial which will measure the efficacy of onabotulinumtoxinA in treating Cervical Dystonia.

    Study Locations

    Location
    Status
    Location
    Springfield, Massachusetts, United States
    Status
    Not applicable